Australian Clinical Labs Ltd (ACL) - Total Assets
Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) holds total assets worth AU$562.50 Million AUD (≈ $398.00 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Australian Clinical Labs Ltd book value and equity for net asset value and shareholders' equity analysis.
Australian Clinical Labs Ltd - Total Assets Trend (2016–2025)
This chart illustrates how Australian Clinical Labs Ltd's total assets have evolved over time, based on quarterly financial data.
Australian Clinical Labs Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Australian Clinical Labs Ltd's total assets of AU$562.50 Million consist of 20.9% current assets and 79.1% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$21.44 Million | 3.7% |
| Accounts Receivable | AU$70.33 Million | 12.2% |
| Inventory | AU$15.62 Million | 2.7% |
| Property, Plant & Equipment | AU$270.11 Million | 47.0% |
| Intangible Assets | AU$6.10 Million | 1.1% |
| Goodwill | AU$159.11 Million | 27.7% |
Asset Composition Trend (2016–2025)
This chart illustrates how Australian Clinical Labs Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Australian Clinical Labs Ltd stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Australian Clinical Labs Ltd's current assets represent 20.9% of total assets in 2025, a decrease from 48.3% in 2016.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, down from 5.8% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 10.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 47.0% of total assets.
Australian Clinical Labs Ltd Competitors by Total Assets
Key competitors of Australian Clinical Labs Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Cryosite Ltd
AU:CTE
|
Australia | AU$19.46 Million |
Australian Clinical Labs Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.59 | 0.58 |
| Quick Ratio | 0.50 | 0.51 | 0.50 |
| Cash Ratio | 0.11 | 0.10 | 0.19 |
| Working Capital | AU$-81.50 Million | AU$-85.67 Million | AU$-77.16 Million |
Australian Clinical Labs Ltd - Advanced Valuation Insights
This section examines the relationship between Australian Clinical Labs Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.55 |
| Latest Market Cap to Assets Ratio | 0.45 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | AU$574.84 Million |
| Market Capitalization | $256.90 Million USD |
Valuation Analysis
Below Book Valuation: The market values Australian Clinical Labs Ltd's assets below their book value (0.45x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Australian Clinical Labs Ltd's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Australian Clinical Labs Ltd (2016–2025)
The table below shows the annual total assets of Australian Clinical Labs Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$574.84 Million ≈ $406.73 Million |
0.00% |
| 2024-12-31 | AU$574.84 Million ≈ $406.73 Million |
-3.07% |
| 2024-06-30 | AU$593.06 Million ≈ $419.63 Million |
0.00% |
| 2023-12-31 | AU$593.06 Million ≈ $419.63 Million |
+2.44% |
| 2023-06-30 | AU$578.91 Million ≈ $409.62 Million |
0.00% |
| 2022-12-31 | AU$578.91 Million ≈ $409.62 Million |
-7.82% |
| 2022-06-30 | AU$628.04 Million ≈ $444.38 Million |
0.00% |
| 2021-12-31 | AU$628.04 Million ≈ $444.38 Million |
+32.30% |
| 2021-06-30 | AU$474.70 Million ≈ $335.88 Million |
0.00% |
| 2020-12-31 | AU$474.70 Million ≈ $335.88 Million |
+29.68% |
| 2020-06-30 | AU$366.05 Million ≈ $259.01 Million |
0.00% |
| 2019-12-31 | AU$366.05 Million ≈ $259.01 Million |
+138.30% |
| 2019-06-30 | AU$153.61 Million ≈ $108.69 Million |
0.00% |
| 2018-12-31 | AU$153.61 Million ≈ $108.69 Million |
+29.02% |
| 2018-06-30 | AU$119.06 Million ≈ $84.24 Million |
0.00% |
| 2017-12-31 | AU$119.06 Million ≈ $84.24 Million |
-1.52% |
| 2017-06-30 | AU$120.89 Million ≈ $85.54 Million |
0.00% |
| 2016-12-31 | AU$120.89 Million ≈ $85.54 Million |
-- |
About Australian Clinical Labs Ltd
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veter… Read more